Identification of glypican-3 as a novel tumor marker for melanoma.
about
NFAT promotes carcinoma invasive migration through glypican-6Proteoglycans in liver cancerDNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4 T cells and CD8 T cellsAggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.Serum anti-BPAG1 auto-antibody is a novel marker for human melanomaProteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growthSignificant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: two case reports.Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy.Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.Glypican-3: a new target for cancer immunotherapy.Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.Immunotherapy targets in pediatric cancer.Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cellsIdentification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancersClinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma.Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwaySyndecan-1: a dynamic regulator of the myeloma microenvironment.Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.killerFLIP: a novel lytic peptide specifically inducing cancer cell death.Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.Yolk sac tumours revisited. A review of their many faces and names.The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand.Shed proteoglycans in tumor stroma.Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model.GPC5 gene and its related pathways in lung cancer.Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer.Glypican-3 expression in clear cell adenocarcinoma of the ovary.WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections.Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.
P2860
Q24336063-D343A203-F4EF-425D-9808-1463072404B2Q26772304-A0D530AF-0708-4AB0-95D1-9B2629F5DEF3Q28277691-3D7F6972-26E2-450B-8BCB-8D231092E0CDQ30487367-5FEEEDE2-C8A5-41BF-AFDB-FE190EC3301FQ30982790-2BD4D35A-9835-487E-97A8-81F2CFA5DACAQ33401908-62F429AE-55C4-44A3-96FF-308E5D3D9EA6Q33858892-99DD1F9D-A3A7-4EA7-A680-33C5C52D8FD7Q33914169-6B385D8E-6B8B-48E6-B001-643799F6751BQ34000565-ACD308FA-2452-49FE-BCE3-D1741B29742BQ34290698-1945B261-D4FA-49FD-B738-5BBEAE421AD5Q34372167-373B4800-9289-4ABE-B402-6CD2F933E072Q34475894-53168DF7-D196-410D-BE33-FECDCC1F0143Q34543102-44B9BE60-2FCE-40D1-8BF6-718E0C5279FAQ34603806-2C0BE7E4-9988-4F47-9056-D7AF4856FBB7Q35971029-BD8B2C7E-E6A2-40F2-982C-6BDF9EBAEA1CQ36321055-15B9D9BD-5C93-4D59-9EEF-66CE2468D920Q36470331-B0BD769B-5BA9-4D37-95B7-840C583954BDQ36524756-248D8933-A880-4C36-BAAF-5C77DF0DBBA6Q36818088-4A8F61AD-9BAF-4820-B767-33638E0AF952Q37008599-2C50DF79-6200-4BDD-9421-26BBC572A37BQ37031710-4DA6E3A0-6C78-4408-8E4E-70FBBBF4C11DQ37240065-AC2A87A7-3D6C-4B0A-9C3C-204E886D0E33Q37278475-B926D015-F845-41E5-9240-128422286D57Q37477273-4DD9ACC1-AB60-418D-9009-BD3831A44C28Q37577463-2A189457-9D11-4D28-9DC6-47C6ED9A0DB3Q37938364-01203DD5-7108-40BB-A9C5-06461A06AC63Q37946956-00F84F96-32FE-4CBC-83CD-470447BCB6B8Q38260167-E51648E8-32E4-476D-A12D-3B217E9BEB58Q38331349-8328EBA3-68B5-4DD0-AC03-641A5E9AE43FQ38882752-D9EF5C05-4567-4AE1-B9DA-32E486B63EB9Q39525572-20881F09-B779-4073-938B-56806392770AQ39661914-8F153245-2865-4E4A-934A-85B1E516D7D0Q41140599-A73D986A-C424-4722-9DF9-F0F2BB219B0AQ41683191-00DBAB81-863A-4C2B-8A92-920FEE3CBD4DQ41786499-DC4469C3-07F4-43C7-8B85-CF0834AC5766Q42108269-1C338784-6E67-4FCE-AFF2-4EA481CA5513Q44268931-CD0D71C4-8204-414A-B874-B9F81FDED4BCQ46957619-E5901202-841C-44CA-86E3-324F92F338F6Q47115713-63A3B44A-12E9-4C4E-A180-FCEAC43C166DQ47119441-055435F6-5605-46A3-ABE7-442FBC10FF9C
P2860
Identification of glypican-3 as a novel tumor marker for melanoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification of glypican-3 as a novel tumor marker for melanoma.
@en
type
label
Identification of glypican-3 as a novel tumor marker for melanoma.
@en
prefLabel
Identification of glypican-3 as a novel tumor marker for melanoma.
@en
P2093
P1476
Identification of glypican-3 as a novel tumor marker for melanoma.
@en
P2093
Mikio Monji
Satoru Senju
Tetsuya Nakatsura
Tomomichi Ono
Toshiro Kageshita
Yasuharu Nishimura
Yoshiaki Ikuta
P304
P356
10.1158/1078-0432.CCR-04-0348
P407
P577
2004-10-01T00:00:00Z